Inventor · disambiguated record
David Bienvenue
Also filed as: BIENVENUE DAVID · BIENVENUE DAVID LEONARD
7 granted patents·4 pending applications·15 citations·filing 2017–2024
80Inventor score
Files withAPTEVO RES & DEVELOPMENT LLC11
Top patents by PatentIndex Score
11 records- 0190US10239949B2Oncofetal antigen binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2018·Granted Mar 26, 2019·6 cites·20 claims
- 0288US11939392B2CD123 binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2021·Granted Mar 26, 2024·1 cites·15 claims
- 0388US10676533B2Methods of treatment of CD123 overexpressing disordersAPTEVO RES & DEVELOPMENT LLC·Filed 2018·Granted Jun 9, 2020·4 cites·9 claims
- 0486US11312786B2Oncofetal antigen binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2019·Granted Apr 26, 2022·2 cites·19 claims
- 0583US11242400B2CD123 binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2017·Granted Feb 8, 2022·2 cites·33 claims
- 0682US12441798B2CD123 binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2024·Granted Oct 14, 2025·0 cites·15 claims
- 0765US11725060B2Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2018·Granted Aug 15, 2023·0 cites·24 claims
- 0857US2024301086A1Tumor-associated antigens and cd3-binding proteins, related compositions, and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2021·Application pending·0 cites
- 0956US2024150483A1COMPOSITIONS COMPRISING 4-1BB and OX40 BINDING PROTEINS AND METHODS OF USEAPTEVO RES & DEVELOPMENT LLC·Filed 2022·Application pending·0 cites
- 1050US2022242962A14-1bb and ox40 binding proteins and related compositions and methods, antibodies against 4-1bb, antibodies against ox40APTEVO RES & DEVELOPMENT LLC·Filed 2020·Application pending·0 cites
- 1150US2023303720A1Formulations for protein therapeuticsAPTEVO RES & DEVELOPMENT LLC·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →